Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Hypercholesterolaemia and risk of coronary heart disease in the elderly: impact of age: the Copenhagen City Heart Study.

Iversen A, Jensen JS, Scharling H, Schnohr P.

Eur J Intern Med. 2009 Mar;20(2):139-44. doi: 10.1016/j.ejim.2008.06.003. Epub 2008 Jul 26.

PMID:
19327601
2.

Microalbuminuria and obesity: impact on cardiovascular disease and mortality.

Klausen KP, Parving HH, Scharling H, Jensen JS.

Clin Endocrinol (Oxf). 2009 Jul;71(1):40-5. doi: 10.1111/j.1365-2265.2008.03427.x. Epub 2008 Sep 18.

PMID:
18803675
3.

Higher prevalence of risk factors for type 2 diabetes mellitus and subsequent higher incidence in men.

Almdal T, Scharling H, Jensen JS, Vestergaard H.

Eur J Intern Med. 2008 Jan;19(1):40-5. doi: 10.1016/j.ejim.2007.05.011. Epub 2007 Sep 27.

PMID:
18206600
5.

Intensity versus duration of walking, impact on mortality: the Copenhagen City Heart Study.

Schnohr P, Scharling H, Jensen JS.

Eur J Cardiovasc Prev Rehabil. 2007 Feb;14(1):72-8.

PMID:
17301630
6.

Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction.

Goetze JP, Mogelvang R, Maage L, Scharling H, Schnohr P, Sogaard P, Rehfeld JF, Jensen JS.

Eur Heart J. 2006 Dec;27(24):3004-10. Epub 2006 Nov 21.

PMID:
17118955
7.

Developing COPD: a 25 year follow up study of the general population.

Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J.

Thorax. 2006 Nov;61(11):935-9.

9.

Exhaled CO, a predictor of lung function?

Fabricius P, Scharling H, Løkke A, Vestbo J, Lange P.

Respir Med. 2007 Mar;101(3):581-6. Epub 2006 Aug 8.

10.

A simple linear model for the effect of changes in metabolic risk factors on coronary heart disease.

Mogelvang R, Scharling H, Jensen JS.

J Intern Med. 2006 Jun;259(6):561-8.

11.
12.

Inhaled corticosteroids and decline of lung function in community residents with asthma.

Lange P, Scharling H, Ulrik CS, Vestbo J.

Thorax. 2006 Feb;61(2):100-4.

13.

The ischemic electrocardiogram: a harbinger for ischemic heart disease independent of the blood pressure level. The Copenhagen City Heart Study.

Larsen CT, Blackburn H, Bruun NE, Jensen GB, Scharling H, Schnohr P.

Eur J Epidemiol. 2005;20(4):301-9.

PMID:
15971501
14.

New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death.

Klausen KP, Scharling H, Jensen G, Jensen JS.

Hypertension. 2005 Jul;46(1):33-7. Epub 2005 May 31.

PMID:
15928029
15.
16.

Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study).

Friberg J, Scharling H, Gadsbøll N, Truelsen T, Jensen GB; Copenhagen City Heart Study.

Am J Cardiol. 2004 Oct 1;94(7):889-94.

PMID:
15464671
17.
18.

Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes.

Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, Appleyard M, Jensen JS.

Circulation. 2004 Jul 6;110(1):32-5. Epub 2004 Jun 21.

PMID:
15210602
19.

Transendothelial lipoprotein exchange and microalbuminuria.

Jensen JS, Feldt-Rasmussen B, Jensen KS, Clausen P, Scharling H, Nordestgaard BG.

Cardiovasc Res. 2004 Jul 1;63(1):149-54.

PMID:
15194471
20.

Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study).

Friberg J, Scharling H, Gadsbøll N, Jensen GB.

Am J Cardiol. 2003 Dec 15;92(12):1419-23.

PMID:
14675577

Supplemental Content

Loading ...
Support Center